720 related articles for article (PubMed ID: 35109786)
1. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
[TBL] [Abstract][Full Text] [Related]
2. Tumor markers as an entry for SARS-CoV-2 infection?
Xia P; Dubrovska A
FEBS J; 2020 Sep; 287(17):3677-3680. PubMed ID: 32738184
[TBL] [Abstract][Full Text] [Related]
3. Role of host factors in SARS-CoV-2 entry.
Evans JP; Liu SL
J Biol Chem; 2021 Jul; 297(1):100847. PubMed ID: 34058196
[TBL] [Abstract][Full Text] [Related]
4. An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.
Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
Curr Top Med Chem; 2021; 21(7):571-596. PubMed ID: 33463470
[TBL] [Abstract][Full Text] [Related]
5. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.
Villa A; Brunialti E; Dellavedova J; Meda C; Rebecchi M; Conti M; Donnici L; De Francesco R; Reggiani A; Lionetti V; Ciana P
Pharmacol Res; 2022 Jan; 175():105982. PubMed ID: 34798263
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
[TBL] [Abstract][Full Text] [Related]
7. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy.
Masre SF; Jufri NF; Ibrahim FW; Abdul Raub SH
Rev Med Virol; 2021 Sep; 31(5):1-9. PubMed ID: 33368788
[TBL] [Abstract][Full Text] [Related]
8. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma.
Geng J; Chen L; Yuan Y; Wang K; Wang Y; Qin C; Wu G; Chen R; Zhang Z; Wei D; Du P; Zhang J; Lin P; Zhang K; Deng Y; Xu K; Liu J; Sun X; Guo T; Yang X; Wu J; Jiang J; Li L; Zhang K; Wang Z; Zhang J; Yan Q; Zhu H; Zheng Z; Miao J; Fu X; Yang F; Chen X; Tang H; Zhang Y; Shi Y; Zhu Y; Pei Z; Huo F; Liang X; Wang Y; Wang Q; Xie W; Li Y; Shi M; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2021 Sep; 6(1):347. PubMed ID: 34564690
[TBL] [Abstract][Full Text] [Related]
9. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).
Katopodis P; Randeva HS; Spandidos DA; Saravi S; Kyrou I; Karteris E
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34935057
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
11. ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019).
Foroozanfar E; Forouzanfar M; Farkhondeh T; Samarghandian S; Forouzanfar F
Curr Drug Discov Technol; 2021; 18(6):e130921189567. PubMed ID: 33371835
[TBL] [Abstract][Full Text] [Related]
12. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
[TBL] [Abstract][Full Text] [Related]
13. An update on ACE2 amplification and its therapeutic potential.
Marquez A; Wysocki J; Pandit J; Batlle D
Acta Physiol (Oxf); 2021 Jan; 231(1):e13513. PubMed ID: 32469114
[TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
Xiang Y; Wang M; Chen H; Chen L
Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003
[TBL] [Abstract][Full Text] [Related]
15. Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection.
Chapoval SP; Keegan AD
Mol Med; 2021 Dec; 27(1):162. PubMed ID: 34961486
[TBL] [Abstract][Full Text] [Related]
16. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
[TBL] [Abstract][Full Text] [Related]
17. The structural basis of accelerated host cell entry by SARS-CoV-2†.
Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD
FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497
[TBL] [Abstract][Full Text] [Related]
18. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology.
Ribeiro DE; Oliveira-Giacomelli Á; Glaser T; Arnaud-Sampaio VF; Andrejew R; Dieckmann L; Baranova J; Lameu C; Ratajczak MZ; Ulrich H
Mol Psychiatry; 2021 Apr; 26(4):1044-1059. PubMed ID: 33328588
[TBL] [Abstract][Full Text] [Related]
19. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
[TBL] [Abstract][Full Text] [Related]
20. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.
Guney C; Akar F
J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]